News
OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
August 24, 2010 9:33 am | by Bio-Medicine.Org | CommentsHOUSTON, Aug. 24 /- OrthoAccel Technologies, Inc. announced this week that it has finalized distribution agreements with two key partners: AB Orthodontics Pty Ltd in Melbourne, Australia, and Inno Dental and Medical Corporation (Inno DMC), based in Seoul, South Korea. (Logo:...
TSI Healthcare Again Recognized in "Healthcare Informatics TOP 100"
August 24, 2010 9:33 am | by Bio-Medicine.Org | CommentsCHAPEL HILL, N.C., Aug. 24 /- TSI Healthcare, a local and national leader in the sales and support of customized technology solutions for physician practices, was recognized for the second consecutive year in the "Healthcare Informatics TOP 100 Vendors" 2010 annual listing. TSI is ranked...
ITelagen Named to Prestigious 2010 Inc. 5000 List of Fastest-Growing Companies
August 24, 2010 9:32 am | by Bio-Medicine.Org | CommentsNEW YORK, Aug. 24 /PRNewswire / -- ITelagen, Inc., a leading provider of healthcare IT and medical billing solutions, today announced that the company was named to the prestigious 2010 Inc. 5000 list, a compendium of the most entrepreneurial and fastest growing companies in America. In...
GP NHS commissioning 'disastrous'
August 24, 2010 8:32 am | by BBC | CommentsHanding GPs control of the health budget and commissioning hospital services would be "disastrous", a medical charity warns.
Mr. Magic Male Enhancer: Undeclared Drug Ingredient
August 24, 2010 8:31 am | by U.S. Food & Drug Administration | CommentsProduct marketed as dietary supplement contains undeclared hydroxythiohomosildenafil and sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Summary Box: Medtronic cuts year outlook after 1Q
August 24, 2010 7:45 am | by The Associated Press | CommentsSOFT MARKET: Medical device maker Medtronic Inc. reported earnings Tuesday inline with analyst estimates. But weakening global demand for implants forced the company to cut full-year guidance.SALES SLUMP: Revenue fell 4 percent in the first quarter to $3.77 billion, impacted by unfavorable foreign...
Biogen developing test to detect risk from MS drug
August 24, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | CommentsBiogen Idec has reported promising early data for a test to help determine which patients taking its multiple sclerosis drug, Tysabri, are at greatest risk for developing a rare but serious brain infection.
Bernard Gordon launches medical imaging startup Photo Diagnostics
August 24, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | CommentsBernard Gordon, founder and former CEO of Analogic Corp. and co-founder of NeuroLogica Corp., has started another company in Danvers-based Photo Diagnostic Systems Inc., and he's invested $5 million as the first institutional funding for the medical imaging startup.
Medtronic cuts 2011 guidance on weaker demand
August 24, 2010 6:45 am | by The Associated Press | CommentsMedtronic Inc., the world's largest medical device maker, reported fiscal first-quarter earnings Tuesday in line with Wall Street expectations, but weaker global demand for medical implants forced the company to slash 2011 earnings expectations.The Minneapolis-based company reported...
Made in America Will Go Away without Investment in STEM-based Education
August 24, 2010 6:36 am | by Society of Manufacturing Engineers | CommentsDEARBORN, Mich., August 23, 2010 - The tagline “Made in America†will go away without increasing investment in STEM-based education. As skilled labor shortages continue to hold back various sectors of U.S. manufacturing, national organizations are looking at their investment...
New Roche deal could net Aileron $1.1B
August 24, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | CommentsAileron Therapeutics Inc., a Cambridge biotech focused on protein-based treatments, has entered into a development deal with Swiss pharmaceutical giant Roche that could bring as much as $1.1 billion to Aileron.
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
August 24, 2010 6:35 am | by Bio-Medicine.Org | CommentsNEW YORK, Aug. 24 /- Regenicin, Inc. (OTC Bulletin Board: WDSTD ), a clinical-stage biotechnology company, announced today that Dr. Joseph Rubinfeld, one of the four original founders of Amgen, Inc., has agreed to join the company's board of directors. Dr. Rubinfeld will be instrumental...
Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market
August 24, 2010 6:35 am | by Bio-Medicine.Org | CommentsEXTON, Pa., Aug. 24 /- BioTrends Research Group, Inc. recently published its TreatmentTrends®: Vascular Access report . This report is based on online survey results from over 150 physicians (general nephrologists, surgeons, interventional radiologists and interventional...
Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board
August 24, 2010 6:34 am | by Bio-Medicine.Org | CommentsNORTH HARBOUR, New Zealand, Aug. 24 /- Rex Bionics Ltd., the company developing a robotic exoskeleton enabling wheelchair users to walk, announced formation of an International Advisory Board that includes Emmy Award-winning U.S. talk show host Montel Williams . Also named to the...
Echo Therapeutics Announces Successful Completion of Clinical Trial for Preludeâ„¢ SkinPrep System and 4% Lidocaine Cream
August 24, 2010 6:34 am | by Bio-Medicine.Org | CommentsFRANKLIN, Mass., Aug. 24 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphonyâ„¢ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Preludeâ„¢ SkinPrep System for transdermal drug...
